Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study
- PMID: 16476103
- DOI: 10.1111/j.1365-2796.2005.01610.x
Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study
Abstract
Objectives: LDL cholesterol is a well-established risk factor for myocardial infarction, but not for stroke. The main objective of the present study was to determine if the risk of stroke is related to the balance between the proatherogenic apoB lipoprotein particles and the antiatherogenic apoA-I particles as is the case for myocardial infarction.
Subjects and design: A total of 98 722 men and 76 831 women were recruited from screening programmes. The prospective risk and the relationships between five different types of fatal strokes and the lipid fractions, apoB, apoA-I and the apoB/apoA-I ratio (automated immunoturbidimetry) were examined. The results were compared with the risks of other ischaemic and non-ischaemic fatalities.
Results: Mean follow-up was 10.3 years. High apoB and low apoA-I values were significantly related to risk of stroke. The odds ratio comparing the upper 10th versus the 1st decile of the apoB/apoA-I ratio for all strokes adjusted for age, gender, total cholesterol (TC) and triglycerides (TG) was 2.07 (95% CI: 1.49-2.88), P < 0.0001. The strongest association was for ischaemic stroke. Low apoA-I was a common abnormality in all stroke subtypes including subarachnoidal and haemorrhagic strokes. In multivariate analyses the apoB/apoA-I ratio was a stronger risk predictor than total/HDL and LDL/HDL cholesterol ratios. The apoB/apoA-I ratio was linearly related to the risk of stroke although the slope was less than observed for the risk of fatal myocardial infarction. For all ischaemic events pooled together the age-, gender-, TC- and TG-adjusted odds ratio, 10th vs. 1st decile, was 3.13 (95% CI: 2.66-3.69), P < 0.0001. By contrast, there was no relationship between the apoB/apoA-I ratio and risk of cancer or any other non-ischaemic causes of death.
Conclusions: These observations link the apoB/apoA-I ratio to the risk of fatal stroke in a similar fashion as for myocardial infarction and other ischaemic events. Our findings indicate that the apoB/apoA-I ratio, which indicates the 'cholesterol balance', is a robust and specific maker of virtually all ischaemic events.
Similar articles
-
Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS).J Intern Med. 2009 Feb;265(2):275-87. doi: 10.1111/j.1365-2796.2008.02016.x. Epub 2008 Nov 14. J Intern Med. 2009. PMID: 19019184
-
Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).J Intern Med. 2008 Jul;264(1):30-8. doi: 10.1111/j.1365-2796.2008.01925.x. Epub 2008 Feb 21. J Intern Med. 2008. PMID: 18298486
-
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.J Intern Med. 2006 May;259(5):455-61. doi: 10.1111/j.1365-2796.2006.01649.x. J Intern Med. 2006. PMID: 16629851
-
The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.J Intern Med. 2006 May;259(5):493-519. doi: 10.1111/j.1365-2796.2006.01643.x. J Intern Med. 2006. PMID: 16629855 Review.
-
Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke.Curr Opin Cardiol. 2007 Jul;22(4):359-67. doi: 10.1097/HCO.0b013e3281bd8849. Curr Opin Cardiol. 2007. PMID: 17556890 Review.
Cited by
-
Ischemic stroke: a cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.Can J Cardiol. 2008 Sep;24(9):705-8. doi: 10.1016/s0828-282x(08)70669-x. Can J Cardiol. 2008. PMID: 18787721 Free PMC article.
-
TLR7 rs2897827 Polymorphism Affects TLR7 Gene mRNA Expression and Serum Apolipoprotein A1 Level of Ischemic Stroke Patients in a Chinese Han Population.J Mol Neurosci. 2016 Jul;59(3):397-403. doi: 10.1007/s12031-016-0773-0. Epub 2016 Jul 18. J Mol Neurosci. 2016. PMID: 27427388
-
Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients.Lipids Health Dis. 2018 May 17;17(1):117. doi: 10.1186/s12944-018-0771-z. Lipids Health Dis. 2018. PMID: 29776362 Free PMC article.
-
Postprandial decrease in LDL-cholesterol in men with metabolic syndrome.Open Med (Wars). 2015 Feb 3;10(1):138-151. doi: 10.1515/med-2015-0025. eCollection 2015. Open Med (Wars). 2015. PMID: 28352689 Free PMC article.
-
Dyslipidemias in the prevention of cardiovascular disease: risks and causality.Curr Cardiol Rep. 2012 Dec;14(6):709-20. doi: 10.1007/s11886-012-0313-7. Curr Cardiol Rep. 2012. PMID: 22965836 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous